查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1829753

2025年全球神經栓塞設備市場報告

Neurovascular Embolization Devices Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，神經血管栓塞器械的市場規模穩定成長，預計2024年將達到13.2億美元，2025年將達到13.8億美元，複合年成長率為4.8%。預測期內的成長歸因於神經血管疾病盛行率的上升、老年人口的成長、對微創手術的需求、醫療基礎設施的改善以及醫療支出的增加。

預計未來幾年神經血管栓塞器械市場規模將強勁成長，到2029年將達到17.8億美元，複合年成長率為6.5%。預測期內的成長歸因於新興市場應用的不斷擴展、對以患者為中心的護理的日益重視、對神經血管疾病認知的不斷提高、成像技術的進步以及研發投入的不斷增加。預測期內的主要趨勢包括個人化治療方法、人工智慧在治療計劃中的整合、下一代栓塞材料的出現、向門診和門診治療的轉變以及創新栓塞技術的開發。

神經血管栓塞裝置是一種醫療工具，透過阻斷或改變血流來處理腦部和中樞神經系統內的不規則血管。它們在神經介入手術中發揮重要作用，旨在治療動脈瘤、介入神經放射學(AVM) 和動靜脈瘻管 (AVF) 等可能導致出血或其他不良後果的疾病。

神經血管栓塞器械類別的主要產品包括栓塞彈簧圈、液體栓塞系統、血流路徑改道支架、動脈瘤夾及其他相關產品。栓塞彈簧圈是由鉑和不銹鋼等材料製成的軟性裝置，用於阻斷血管內的血流。它們可用於治療多種疾病，包括中風和出血性中風，以及腦動脈瘤和動靜脈畸形。這些器械的終端使用者包括醫院和門診手術中心等。

2025年春季美國關稅的突然上調及其引發的貿易摩擦對醫療設備行業產生了重大影響，尤其對用於診斷影像設備的進口零件、手術用不銹鋼和一次性塑膠製品產生了重大影響。由於醫院和診所抵制漲價，製造商面臨利潤壓力。監管挑戰使情況更加複雜，因為由於關稅而更換供應商通常需要重新認證醫療設備，導致市場進入延遲。為此，企業正在透過雙重採購關鍵零件、增加標準化產品的國內生產以及加快尋找更具成本效益的材料來降低風險。

本研究報告是商業研究公司 (The Business Research Company) 新報告系列的一部分，該系列提供神經栓塞器材市場統計數據，包括全球市場規模、區域佔有率、神經栓塞器材市場佔有率的競爭對手、詳細的神經栓塞器材細分市場、市場趨勢以及行業商機。這些神經栓塞器材市場研究報告透過深入分析產業現狀和未來趨勢，為您提供全面的展望。

我們對該市場未來五年6.5%的成長率預測與先前保持不變。下降的主要原因是美國與其他國家之間關稅的影響。這種影響將透過對法國鉑金微彈簧圈徵收關稅對美國產生直接影響，從而提高動脈瘤修復系統的價格，並影響挽救生命的介入神經放射學手術的可負擔性。由於互惠關稅以及貿易緊張局勢和限制加劇對全球經濟和貿易的負面影響，這種影響也將更加廣泛。

出血發生率的上升預計將推動神經血管栓塞裝置市場的發展。出血是指透過皮膚或黏膜破裂在內部或外部發生的異常且無法控制的出血。人口老化、高血壓加劇以及抗凝血劑的廣泛使用導致了出血的流行。神經血管栓塞裝置透過阻斷異常血管，從而控制出血並避免進一步的腦損傷，在治療出血性中風方面發揮關鍵作用。例如，倫敦國王學院最近進行的一項研究預測，到 2050 年，英國70 至 95 歲人群中因腦出血（一種特定類型的出血）導致的病例和死亡人數將增加 59.4%。因此，腦出血盛行率的上升正在推動神經血管栓塞裝置市場的成長。

為了應對腦動脈瘤並增強市場競爭力，神經血管栓塞器械領域的主要企業正專注於開發技術先進的產品，例如屏蔽技術。屏蔽技術是指旨在提高腦動脈瘤治療器械的有效性和安全性，同時提高其整體耐用性和使用壽命的先進功能。例如，總部位於愛爾蘭的醫療技術公司Medtronic PLC) 於2022年6月在印度推出了其第四代流量轉向器——採用屏蔽技術的Pipeline Vantage。此器械的設計特點經過改進，使其在血管內手術中更易於使用且可靠。該器械旨在促進血管內膜細胞增殖，從而輔助微創治療動脈瘤，降低破裂風險並改善患者預後。

2023年5月，美國醫療科技公司史賽克（Stryker Corporation）以5.3億美元收購了Cerus Endovascular Ltd。史賽克的這項策略性措施旨在增強其在提供治療顱內動脈瘤的創新醫療設備方面的專業知識，包括Contour神經血管系統和NeqStent線圈輔助血流轉向器等產品。 Cerus Endovascular Ltd總部位於愛爾蘭，專注於開發用於治療顱內動脈瘤的尖端神經血管栓塞器械。

神經血管栓塞設備市場的主要參與企業包括強生公司、雅培實驗室、美敦力公司、賀利氏控股、史賽克公司、波士頓科學公司、鐘化公司、泰爾茂公司、B Braun Melsungen AG、Cook Medical LLC、Integer Holdings Corporation、Merit Medical Systems Inc、Penumbra Inc、Asahi Inteccop Cop、Mr.alr Ltd. Co KG、Rapid Medical Ltd、Emboline Inc、InspireMD Inc、QXMedical LLC、Vesalio LLC 和 EmbolX Inc。

2024年神經栓塞設備市場最大的地區是北美。預計亞太地區將成為預測期內成長最快的地區。神經栓塞設備市場報告涵蓋的地區包括亞太地區、西歐、中歐和東歐、北美、南美以及中東和非洲。

神經血管栓塞裝置市場報告涵蓋的國家有澳洲、巴西、中國、法國、德國、印度、印尼、日本、俄羅斯、韓國、美國、英國、加拿大、義大利和西班牙。

神經血管栓塞器械市場包括顆粒栓塞、可分離球囊、血管栓塞和栓塞微球的銷售。該市場的價值為“出廠價”，即商品製造商或創造者銷售的商​​品價值，無論是出售給其他營業單位（包括下游製造商、批發商、經銷商和零售商），還是直接出售給最終客戶。該市場商品的價值還包括商品創造者銷售的任何相關服務。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通膨、地緣政治、貿易戰和關稅，以及新冠疫情和復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球神經血管栓塞設備：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
  • 最終用途產業分析
  • 全球神經栓塞設備市場：成長率分析
  • 全球神經栓塞設備市場表現：規模與成長，2019-2024
  • 全球神經栓塞設備市場預測：規模與成長，2024-2029，2034
  • 全球神經栓塞設備：總目標市場（TAM）

第6章 市場細分

  • 全球神經栓塞設備市場（按產品、性能和預測），2019-2024 年、2024-2029 年、2034 年
  • 栓塞線圈
  • 液體栓塞系統
  • 血流晶粒支架
  • 動脈瘤夾
  • 其他
  • 全球神經栓塞設備市場（按治療、表現和預測），2019-2024 年、2024-2029 年、2034 年
  • 缺血性中風解決方案
  • 出血性中風解決方案
  • 全球神經栓塞設備市場（按適應症、表現和預測），2019-2024 年、2024-2029 年、2034 年
  • 腦動脈瘤
  • 動靜脈畸形
  • 其他
  • 全球神經栓塞設備市場（按最終用戶、性能和預測），2019-2024 年、2024-2029 年、2034 年
  • 醫院
  • 門診手術中心
  • 其他
  • 全球神經血管栓塞設備市場：栓塞線圈細分，按類型、性能和預測，2019-2024 年、2024-2029 年、2034 年
  • 可拆卸線圈
  • 白金裸線圈
  • 水凝膠塗層彈簧圈
  • 全球神經血管栓塞設備市場：液體栓塞系統細分，按類型、性能和預測，2019-2024 年、2024-2029 年、2034 年
  • 戊二醛液體栓塞
  • Onyx液體栓塞系統
  • 全球神經血管栓塞設備市場：血流晶粒支架細分市場，按類型、性能和預測，2019-2024 年、2024-2029 年、2034 年
  • 層級構造支架
  • 用於動脈瘤治療的分流器
  • 全球神經血管栓塞設備市場：動脈瘤夾細分市場，按類型、性能和預測，2019-2024 年、2024-2029 年、2034 年
  • 鈦夾
  • 不銹鋼夾
  • 全球神經栓塞設備市場：其他細分市場、按類型、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 栓塞球囊
  • 微導管

第7章 區域和國家分析

  • 全球神經栓塞設備市場：2019-2024 年、2024-2029 年和 2034 年區域表現和預測
  • 全球神經栓塞設備市場：國家、績效及預測（2019-2024、2024-2029、2034）

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章：澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

  • 神經栓塞裝置市場：競爭格局
  • 神經栓塞設備市場：公司簡介
    • Johnson & Johnson
    • Abbott Laboratories
    • Medtronic plc
    • Heraeus Holding
    • Stryker Corporation

第31章：其他領先和創新企業

  • Boston Scientific Corporation
  • Kaneka Corporation
  • Terumo Corporation
  • B Braun Melsungen AG
  • Cook Medical LLC
  • Integer Holdings Corporation
  • Merit Medical Systems Inc
  • Penumbra Inc
  • Asahi Intecc Co Ltd
  • MicroVention Inc
  • Balt USA LLC
  • Imperative Care Inc
  • InNeuroCo Inc
  • Acandis GmbH & Co KG
  • Rapid Medical Ltd

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第35章：市場潛力大的國家與策略

  • 2029年神經栓塞設備市場：提供新機會的國家
  • 2029年神經栓塞設備市場：細分市場帶來新機會
  • 2029年神經栓塞設備市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第36章 附錄

簡介目錄
Product Code: r30785u

Neurovascular embolization devices are medical tools utilized to address irregular blood vessels in the brain or central nervous system by obstructing or altering blood flow. They play a crucial role in neuro-interventional treatments aimed at addressing conditions such as aneurysms, arteriovenous malformations (AVMs), and arteriovenous fistulas (AVFs) that could lead to bleeding or other adverse outcomes.

The primary products within the category of neurovascular embolization devices comprise embolization coils, liquid embolic systems, flow diversion stents, aneurysm clips, and other related items. Embolization coils, constructed from materials such as platinum or stainless steel, are flexible devices employed to block blood flow within vessels. They are utilized in diverse treatments such as ischemic and hemorrhagic stroke solutions and are indicated for conditions such as brain aneurysms and arteriovenous malformations. These devices are utilized by various end-users including hospitals, ambulatory surgical centers, and others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.

The neurovascular embolization devices market research report is one of a series of new reports from The Business Research Company that provides neurovascular embolization devices market statistics, including the neurovascular embolization devices industry global market size, regional shares, competitors with neurovascular embolization devices market share, detailed neurovascular embolization devices market segments, market trends, and opportunities, and any further data you may need to thrive in the neurovascular embolization devices industry. These neurovascular embolization devices market research reports deliver a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The neurovascular embolization devices market size has grown steadily in recent years. It will grow from $1.32 billion in 2024 to $1.38 billion in 2025 at a compound annual growth rate (CAGR) of 4.8%. The growth in the historic period can be attributed to the increased prevalence of neurovascular disorders, the rising geriatric population, the demand for minimally invasive procedures, improved healthcare infrastructure, and increased healthcare expenditure.

The neurovascular embolization devices market size is expected to see strong growth in the next few years. It will grow to $1.78 billion in 2029 at a compound annual growth rate (CAGR) of 6.5%. The growth in the forecast period can be attributed to expanding applications in emerging markets, emphasis on patient-centric care, rising awareness about neurovascular disorders, advancements in imaging technologies, and increasing investments in research and development. Major trends in the forecast period include personalized treatment approaches, integration of artificial intelligence in treatment planning, the emergence of next-generation embolic materials, shift towards outpatient and ambulatory procedures and development of innovative embolization techniques.

The forecast of 6.5% growth over the next five years remains unchanged from the previous projection for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through tariffs on platinum microcoils from France, raising prices for aneurysm treatment systems and impacting the affordability of life-saving neurointerventional procedures.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The increasing incidence of hemorrhages is anticipated to drive the neurovascular embolization devices market forward. Hemorrhages represent abnormal and uncontrollable bleeding occurring either internally within the body or externally through breaks in the skin or mucous membranes. Factors contributing to the prevalence of hemorrhages include aging populations, heightened occurrences of hypertension, and expanded usage of anticoagulant medications. Neurovascular embolization devices play a crucial role in managing hemorrhagic strokes by blocking abnormal blood vessels, thereby reducing bleeding and averting further brain damage. For example, recent research conducted by King's College London indicates an expected 59.4% increase in cases and deaths from intracerebral hemorrhage (a specific type of hemorrhage) among individuals aged 70 to 95 across the UK by 2050. Consequently, the mounting prevalence of hemorrhages propels the growth of the neurovascular embolization devices market.

Major companies in the neurovascular embolization devices sector are concentrating on the development of technologically advanced products, such as shield technology, to address brain aneurysms and enhance their competitive position in the market. Shield Technology denotes an advanced attribute aimed at augmenting the effectiveness and safety of these devices while also contributing to their overall durability and longevity. For example, in June 2022, Medtronic PLC, an Ireland-based healthcare technology company, introduced the Pipeline Vantage with Shield Technology, a fourth-generation flow diverter in India. This device incorporates enhanced design features to enhance usability and reliability during endovascular procedures. By fostering cell growth in the blood vessel's inner lining, the device provides a scaffold that aids in the minimally invasive treatment of aneurysms, reduces the risk of rupture, and enhances patient outcomes.

In May 2023, Stryker Corporation, a US-based medical technology company, completed the acquisition of Cerus Endovascular Ltd for $530 million. This strategic move by Stryker was aimed at strengthening its expertise in offering innovative medical devices tailored for treating intracranial aneurysms, including products such as the contour neurovascular system and the neqstent coil-assisted flow diverter. Cerus Endovascular Ltd, headquartered in Ireland, specializes in the development of cutting-edge neurovascular embolization devices designed specifically for the treatment of intracranial aneurysms.

Major companies operating in the neurovascular embolization devices market are Johnson & Johnson, Abbott Laboratories, Medtronic plc, Heraeus Holding, Stryker Corporation, Boston Scientific Corporation, Kaneka Corporation, Terumo Corporation, B Braun Melsungen AG, Cook Medical LLC, Integer Holdings Corporation, Merit Medical Systems Inc, Penumbra Inc, Asahi Intecc Co Ltd, MicroVention Inc, Balt USA LLC, Imperative Care Inc, InNeuroCo Inc, Acandis GmbH & Co KG, Rapid Medical Ltd, Emboline Inc, InspireMD Inc, QXMedical LLC, Vesalio LLC, EmbolX Inc

North America was the largest region in the neurovascular embolization devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the neurovascular embolization devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the neurovascular embolization devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The neurovascular embolization devices market consists of sales of particle embolic, detachable balloons, vascular plugs, and embolization microspheres. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Neurovascular Embolization Devices Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on neurovascular embolization devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for neurovascular embolization devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The neurovascular embolization devices market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product: Embolization Coils; Liquid Embolic Systems; Flow Diversion Stents; Aneurysm Clips; Other Products
  • 2) By Treatment: Ischemic Stroke Solution; Hemorrhagic Stroke Solutions
  • 3) By Indication: Brain Aneurysms; Arteriovenous Malformation; Other Indications
  • 4) By End User: Hospitals; Ambulatory Surgical Centers; Other End Users
  • Subsegments:
  • 1) By Embolization Coils: Detachable Coils; Bare Platinum Coils; Coils With Hydrogel Coatings
  • 2) By Liquid Embolic Systems: Gluteraldehyde-Based Liquid Embolization; Onyx Liquid Embolic System
  • 3) By Flow Diversion Stents: Stents With Dual-Layer Technology; Flow Diverters For Aneurysm Treatment
  • 4) By Aneurysm Clips: Titanium Clips; Stainless Steel Clips
  • 5) By Other Products: Balloons For Embolization; Microcatheters
  • Companies Mentioned: Johnson & Johnson; Abbott Laboratories; Medtronic plc; Heraeus Holding; Stryker Corporation; Boston Scientific Corporation; Kaneka Corporation; Terumo Corporation; B Braun Melsungen AG; Cook Medical LLC; Integer Holdings Corporation; Merit Medical Systems Inc; Penumbra Inc; Asahi Intecc Co Ltd; MicroVention Inc; Balt USA LLC; Imperative Care Inc; InNeuroCo Inc; Acandis GmbH & Co KG; Rapid Medical Ltd; Emboline Inc; InspireMD Inc; QXMedical LLC; Vesalio LLC; EmbolX Inc
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Neurovascular Embolization Devices Market Characteristics

3. Neurovascular Embolization Devices Market Trends And Strategies

4. Neurovascular Embolization Devices Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Neurovascular Embolization Devices Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Neurovascular Embolization Devices PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Neurovascular Embolization Devices Market Growth Rate Analysis
  • 5.4. Global Neurovascular Embolization Devices Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Neurovascular Embolization Devices Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Neurovascular Embolization Devices Total Addressable Market (TAM)

6. Neurovascular Embolization Devices Market Segmentation

  • 6.1. Global Neurovascular Embolization Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Embolization Coils
  • Liquid Embolic Systems
  • Flow Diversion Stents
  • Aneurysm Clips
  • Other Products
  • 6.2. Global Neurovascular Embolization Devices Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Ischemic Stroke Solution
  • Hemorrhagic Stroke Solutions
  • 6.3. Global Neurovascular Embolization Devices Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Brain Aneurysms
  • Arteriovenous Malformation
  • Other Indications
  • 6.4. Global Neurovascular Embolization Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Ambulatory Surgical Centers
  • Other End Users
  • 6.5. Global Neurovascular Embolization Devices Market, Sub-Segmentation Of Embolization Coils, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Detachable Coils
  • Bare Platinum Coils
  • Coils With Hydrogel Coatings
  • 6.6. Global Neurovascular Embolization Devices Market, Sub-Segmentation Of Liquid Embolic Systems, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Gluteraldehyde-Based Liquid Embolization
  • Onyx Liquid Embolic System
  • 6.7. Global Neurovascular Embolization Devices Market, Sub-Segmentation Of Flow Diversion Stents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Stents With Dual-Layer Technology
  • Flow Diverters For Aneurysm Treatment
  • 6.8. Global Neurovascular Embolization Devices Market, Sub-Segmentation Of Aneurysm Clips, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Titanium Clips
  • Stainless Steel Clips
  • 6.9. Global Neurovascular Embolization Devices Market, Sub-Segmentation Of Other Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Balloons For Embolization
  • Microcatheters

7. Neurovascular Embolization Devices Market Regional And Country Analysis

  • 7.1. Global Neurovascular Embolization Devices Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Neurovascular Embolization Devices Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Neurovascular Embolization Devices Market

  • 8.1. Asia-Pacific Neurovascular Embolization Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Neurovascular Embolization Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Neurovascular Embolization Devices Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Neurovascular Embolization Devices Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Neurovascular Embolization Devices Market

  • 9.1. China Neurovascular Embolization Devices Market Overview
  • 9.2. China Neurovascular Embolization Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Neurovascular Embolization Devices Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Neurovascular Embolization Devices Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Neurovascular Embolization Devices Market

  • 10.1. India Neurovascular Embolization Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Neurovascular Embolization Devices Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Neurovascular Embolization Devices Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Neurovascular Embolization Devices Market

  • 11.1. Japan Neurovascular Embolization Devices Market Overview
  • 11.2. Japan Neurovascular Embolization Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Neurovascular Embolization Devices Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Neurovascular Embolization Devices Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Neurovascular Embolization Devices Market

  • 12.1. Australia Neurovascular Embolization Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Neurovascular Embolization Devices Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Neurovascular Embolization Devices Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Neurovascular Embolization Devices Market

  • 13.1. Indonesia Neurovascular Embolization Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Neurovascular Embolization Devices Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Neurovascular Embolization Devices Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Neurovascular Embolization Devices Market

  • 14.1. South Korea Neurovascular Embolization Devices Market Overview
  • 14.2. South Korea Neurovascular Embolization Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Neurovascular Embolization Devices Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Neurovascular Embolization Devices Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Neurovascular Embolization Devices Market

  • 15.1. Western Europe Neurovascular Embolization Devices Market Overview
  • 15.2. Western Europe Neurovascular Embolization Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Neurovascular Embolization Devices Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Neurovascular Embolization Devices Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Neurovascular Embolization Devices Market

  • 16.1. UK Neurovascular Embolization Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Neurovascular Embolization Devices Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Neurovascular Embolization Devices Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Neurovascular Embolization Devices Market

  • 17.1. Germany Neurovascular Embolization Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Neurovascular Embolization Devices Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Neurovascular Embolization Devices Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Neurovascular Embolization Devices Market

  • 18.1. France Neurovascular Embolization Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Neurovascular Embolization Devices Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Neurovascular Embolization Devices Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Neurovascular Embolization Devices Market

  • 19.1. Italy Neurovascular Embolization Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Neurovascular Embolization Devices Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Neurovascular Embolization Devices Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Neurovascular Embolization Devices Market

  • 20.1. Spain Neurovascular Embolization Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Neurovascular Embolization Devices Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Neurovascular Embolization Devices Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Neurovascular Embolization Devices Market

  • 21.1. Eastern Europe Neurovascular Embolization Devices Market Overview
  • 21.2. Eastern Europe Neurovascular Embolization Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Neurovascular Embolization Devices Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Neurovascular Embolization Devices Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Neurovascular Embolization Devices Market

  • 22.1. Russia Neurovascular Embolization Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Neurovascular Embolization Devices Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Neurovascular Embolization Devices Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Neurovascular Embolization Devices Market

  • 23.1. North America Neurovascular Embolization Devices Market Overview
  • 23.2. North America Neurovascular Embolization Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Neurovascular Embolization Devices Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Neurovascular Embolization Devices Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Neurovascular Embolization Devices Market

  • 24.1. USA Neurovascular Embolization Devices Market Overview
  • 24.2. USA Neurovascular Embolization Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Neurovascular Embolization Devices Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Neurovascular Embolization Devices Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Neurovascular Embolization Devices Market

  • 25.1. Canada Neurovascular Embolization Devices Market Overview
  • 25.2. Canada Neurovascular Embolization Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Neurovascular Embolization Devices Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Neurovascular Embolization Devices Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Neurovascular Embolization Devices Market

  • 26.1. South America Neurovascular Embolization Devices Market Overview
  • 26.2. South America Neurovascular Embolization Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Neurovascular Embolization Devices Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Neurovascular Embolization Devices Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Neurovascular Embolization Devices Market

  • 27.1. Brazil Neurovascular Embolization Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Neurovascular Embolization Devices Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Neurovascular Embolization Devices Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Neurovascular Embolization Devices Market

  • 28.1. Middle East Neurovascular Embolization Devices Market Overview
  • 28.2. Middle East Neurovascular Embolization Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Neurovascular Embolization Devices Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Neurovascular Embolization Devices Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Neurovascular Embolization Devices Market

  • 29.1. Africa Neurovascular Embolization Devices Market Overview
  • 29.2. Africa Neurovascular Embolization Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Neurovascular Embolization Devices Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Neurovascular Embolization Devices Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Neurovascular Embolization Devices Market Competitive Landscape And Company Profiles

  • 30.1. Neurovascular Embolization Devices Market Competitive Landscape
  • 30.2. Neurovascular Embolization Devices Market Company Profiles
    • 30.2.1. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Heraeus Holding Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Stryker Corporation Overview, Products and Services, Strategy and Financial Analysis

31. Neurovascular Embolization Devices Market Other Major And Innovative Companies

  • 31.1. Boston Scientific Corporation
  • 31.2. Kaneka Corporation
  • 31.3. Terumo Corporation
  • 31.4. B Braun Melsungen AG
  • 31.5. Cook Medical LLC
  • 31.6. Integer Holdings Corporation
  • 31.7. Merit Medical Systems Inc
  • 31.8. Penumbra Inc
  • 31.9. Asahi Intecc Co Ltd
  • 31.10. MicroVention Inc
  • 31.11. Balt USA LLC
  • 31.12. Imperative Care Inc
  • 31.13. InNeuroCo Inc
  • 31.14. Acandis GmbH & Co KG
  • 31.15. Rapid Medical Ltd

32. Global Neurovascular Embolization Devices Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Neurovascular Embolization Devices Market

34. Recent Developments In The Neurovascular Embolization Devices Market

35. Neurovascular Embolization Devices Market High Potential Countries, Segments and Strategies

  • 35.1 Neurovascular Embolization Devices Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Neurovascular Embolization Devices Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Neurovascular Embolization Devices Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer